Residential treatment compared with outpatient treatment for tobacco use and dependence
- PMID: 21307389
- PMCID: PMC3046940
- DOI: 10.4065/mcp.2010.0703
Residential treatment compared with outpatient treatment for tobacco use and dependence
Abstract
Objective: To compare the effectiveness of outpatient vs residential treatment for tobacco dependence in a large referral practice.
Patients and methods: We analyzed data from 2 cohorts of cigarette smokers who received either comprehensive outpatient or intensive 8-day residential treatment for tobacco dependence between January 1, 2004, and December 31, 2007. Self-reported 7-day point prevalence abstinence from smoking at 6 months was obtained via telephone interview. Logistic regression was used to assess the likelihood of increased abstinence with residential treatment.
Results: Overall, 4327 cigarette smokers received comprehensive outpatient treatment for tobacco dependence, and 226 smokers received treatment in an intensive 8-day residential program. Compared with outpatients, residential patients smoked more cigarettes per day (mean ± SD, 31.1 ± 14.4 vs 21.2 ± 11.2), had more severe nicotine dependence (Fagerström Test for Nicotine Dependence score, 6.9 ± 2.0 vs 5.1 ± 2.3), and were more likely to have been treated for alcoholism (58/222 [26%] vs 649/4327 [15%]) or depression (124/222 [56%] vs 1817/4327 [42%]; P<.001 for all comparisons). The 6-month smoking abstinence rate was significantly higher for residential patients compared with outpatients (115/222 [52%] vs 1168/4327 [27%]; unadjusted odds ratio, 3.0; 95% confidence interval, 2.3-3.9), with similar findings after adjusting for baseline characteristics (adjusted odds ratio, 3.58; 95% confidence interval, 2.6-4.9).
Conclusion: Compared with smokers who received outpatient treatment, those who received residential treatment had more severe tobacco dependence. Residential treatment for tobacco dependence was associated with a significantly greater odds of 6-month smoking abstinence compared with outpatient treatment among smokers in a referral clinic setting.
Figures
Comment in
-
Underlying reasons for smoking.Mayo Clin Proc. 2011 May;86(5):469; author reply 469. doi: 10.4065/mcp.2011.0157. Mayo Clin Proc. 2011. PMID: 21531889 Free PMC article. No abstract available.
Similar articles
-
Residential (inpatient) treatment compared with outpatient treatment for nicotine dependence.Mayo Clin Proc. 2001 Feb;76(2):124-33. doi: 10.1016/S0025-6196(11)63117-0. Mayo Clin Proc. 2001. PMID: 11213299
-
Efficacy of a short-term residential smoking cessation therapy versus standard outpatient group therapy ('START-Study'): study protocol of a randomized controlled trial.Trials. 2020 Jun 23;21(1):562. doi: 10.1186/s13063-020-04253-x. Trials. 2020. PMID: 32576275 Free PMC article.
-
Comparative Effectiveness of Varenicline and Nicotine Replacement Therapy for Smoking Cessation in Older and Younger Smokers: A Prospective Cohort in Taiwan.Nicotine Tob Res. 2019 Jan 4;21(2):149-155. doi: 10.1093/ntr/ntx275. Nicotine Tob Res. 2019. PMID: 29294121 Free PMC article.
-
Treatment Outcomes From a Specialist Model for Treating Tobacco Use Disorder in a Medical Center.Medicine (Baltimore). 2015 Nov;94(44):e1903. doi: 10.1097/MD.0000000000001903. Medicine (Baltimore). 2015. PMID: 26554789 Free PMC article.
-
Residential Treatment Exclusively for Tobacco Use Disorder: A Narrative Review.J Addict Med. 2024 Jan-Feb 01;18(1):33-41. doi: 10.1097/ADM.0000000000001234. Epub 2023 Oct 17. J Addict Med. 2024. PMID: 37847568 Review.
Cited by
-
Residential treatment exclusively for smoking cessation in patients with Crohn's disease: Results from a pilot study.Tob Induc Dis. 2022 Jun 23;20:60. doi: 10.18332/tid/149481. eCollection 2022. Tob Induc Dis. 2022. PMID: 35836910 Free PMC article.
-
Effectiveness of National Residential Smoking Cessation Program.Int J Environ Res Public Health. 2021 Sep 20;18(18):9901. doi: 10.3390/ijerph18189901. Int J Environ Res Public Health. 2021. PMID: 34574823 Free PMC article.
-
Successful Smoking Cessation among Women Smokers Based on Utilizing National Smoking Cessation Service Type in Korea.Int J Environ Res Public Health. 2021 Jun 18;18(12):6578. doi: 10.3390/ijerph18126578. Int J Environ Res Public Health. 2021. PMID: 34207330 Free PMC article.
-
Patterns and predictors of smoking relapse among inpatient smoking intervention participants: a 1-year follow-up study in Korea.Epidemiol Health. 2021;43:e2021043. doi: 10.4178/epih.e2021043. Epub 2021 Jun 9. Epidemiol Health. 2021. PMID: 34126705 Free PMC article.
-
Strategies for Referring Cancer Patients in a Smoking Cessation Program.Int J Environ Res Public Health. 2020 Aug 21;17(17):6089. doi: 10.3390/ijerph17176089. Int J Environ Res Public Health. 2020. PMID: 32825665 Free PMC article.
References
-
- Centers for Disease Control (CDC) Annual smoking-attributable mortality, years of potential life lost, and economic costs–United States, 1995-1999. MMWR Morb Mortal Wkly Rep. 2002;51(14)300-303 - PubMed
-
- Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000 [published corrections appear in JAMA. 2005;293(3):293-294 and 2005;293(3):298]. JAMA. 2004;291(10)1238-1245 - PubMed
-
- Center for Disease Control (CDC) Prevalence of current smoking among adults aged 18 years and over: United States, 1997-June 2009. National Health Interview Survey. www.cdc.gov/nchs/data/nhis/earlyrelease/200912_08.pdf Accessed January 19, 2011
-
- Fiore MC, Jaen CR, Baker TB, et al. Treating Tobacco Use and Dependence: 2008 Update. Rockville, MD: US Dept of Health and Human Services, Public Health Service; 2008.
-
- Lancaster T, Hajek P, Stead LF, West R, Jarvis MJ. Prevention of relapse after quitting smoking: a systematic review of trials. Arch Intern Med. 2006;166(8)828-835 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
